Skip to main content
Terug
Watch Compare

Autonomix Medical, Inc.

Datakwaliteit: 100%
AMIX
NASDAQ Manufacturing Measuring & Analyzing Instruments
€ 0,40
▲ € 0,01 (2,10%)
6 months return
—
Momentum
Neutral
ROE
-229,77%

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-229,77%
Onder sectorgemiddelde (-54,47%)
ROIC-184,78%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio6,18
Interest Coverage-230,91

Waardering

PE (TTM)
-0,26
Boven sectorgemiddelde (-1,49)
P/B Ratio0,53
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -11,95 M

Price History

Financiële Trends

Koersdoel Analisten

1 analist
Strong Buy
+395.4%
upside to target
Huidig
€ 0,40
Consensus Target
€ 2,00
€ 2,00
Laag
€ 2,00
Hoog
Vooruitzicht
Forward WPA
-€ 1,63
Omzet Sch.
0,0

Winstverassingen

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -€ 0,26 · Rev Est: 0,0
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -€ 0,74 -€ 1,07 -€ 1,38 -€ 0,36 — —
Estimate -€ 1,24 -€ 0,98 -€ 1,50 -€ 0,46 -€ 0,26 -€ 0,44
Verrassing +40,08% -9,18% +8,00% +21,74% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -229,77% · Net Margin: N/A
Revenue (TTM) 0,0 Net Income (TTM) -17,24 M
ROE -229,77% ROA -190,05%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -11,95 M
ROIC -184,78% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 6,18
Debt / Equity N/A Current Ratio 6,18
Interest Coverage -230,91 Asset Turnover 0,00
Working Capital 8,54 M Tangible Book Value 8,56 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0,26 · EV/EBITDA: N/A
P/E Ratio -0,26 Forward P/E N/A
P/B Ratio 0,53 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -261,96%
Market Cap 4,56 M Enterprise Value -5,37 M

Per Share

EPS: N/A · FCF/Share: -1,05
EPS (Diluted TTM) N/A Revenue / Share 0,00
FCF / Share -1,05 OCF / Share -1,05
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 69,33% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 69,33%
SBC-Adj. FCF -13,70 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue 0,0 0,0
Net Income -11,41 M -15,43 M
EPS (Diluted) — —
Gross Profit — —
Operating Income -11,59 M -12,03 M
EBITDA — —
R&D Expenses 4,73 M 2,23 M
SG&A Expenses — —
D&A 183.000,0 81.000,0
Interest Expense 176.000,0 79.000,0
Income Tax 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets 9,81 M 9,41 M
Total Liabilities 1,71 M 1,78 M
Shareholders' Equity 8,10 M 7,63 M
Total Debt — —
Cash & Equivalents 9,14 M 8,61 M
Current Assets 9,61 M 9,39 M
Current Liabilities 1,71 M 777.000,0

Sectorvergelijking

vs Manufacturing sector mediaan (1605 peers)
Metriek Aandeel Sector Mediaan
P/E -0,3 -1,5
P/B 0,5 1,6
ROE % -229,8 -54,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3